Powering High-Value Decisions with
Precision Insights
Since 1998, Kalorama, part of Science and Medicine Group, has been a trusted leader in life science market intelligence for top IVD manufacturers, investors, and healthcare stakeholders. While others spread thin across multiple verticals, we go deep – specializing in sectors like IVD, medical devices, biotechnology, and pharmaceuticals. Our goal is simple: turn data into clear actionable insights so business can make smarter decisions, identify growth opportunities, and stay ahead of change.
Industries We Serve
Healthcare • Biotechnology • Laboratory Diagnostics • Medical Devices • Pharmaceuticals
Our Solutions
Explore our comprehensive suite of solutions, designed to drive your success. Why? Because when you succeed, science and medicine move forward.
Latest Resource
How Telehealth and Decentralized Care Models Are Exposing Weaknesses in Provider Verification Processes
June 30, 2026
Karthik Achari, founder of PepMD (Guest Contributor)
Guest Contributor Karthik Achari, founder of PepMD, explores why traditional provider verification processes are struggling to keep pace with the rapid expansion of telehealth and decentralized care models. Today’s patients will probably check online ratings before making an appointment with a healthcare professional. They’ll look at factors such as how friendly the staff is and…
Latest Market Reports
Our syndicated reports are vital tools for companies aiming to develop and implement effective market strategies. View our latest reports below.
30-Country IVD Market Atlas, 2026 – July Update
July 20, 2026
Kalorama Information’s 30-Country IVD Market Atlas, 2026 provides a comprehensive analysis of the in vitro diagnostic (IVD) markets across 30 key countries, including the United States, China, Germany, United Kingdom, Saudi Arabia, India, Japan, France, Vietnam, and Turkey, among others. This in-depth report delivers detailed market sizing and forecasts spanning five years, tracking 18 IVD…
Price range: $5,600.00 through $8,000.00
Target Enrichment and Library Preparation for Next-Generation Sequencing, 2026
July 7, 2026
As next-generation sequencing expands into clinical diagnostics and precision oncology, upstream sample preparation is under growing scrutiny. This Kalorama report sizes the global NGS library preparation and target enrichment market through 2030, with competitive share estimates and in-depth profiles of 13 leading suppliers including Illumina, Twist Bioscience, IDT, and Thermo Fisher.
Price range: $5,600.00 through $8,000.00
Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 13th Edition
June 3, 2026
Now in its thirteenth edition — Worldwide Market for Point-of-Care (POC) Diagnostic Tests analyzes the global POC diagnostics market with updated insights and forecasts through 2030.
Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 13th Edition delivers a comprehensive, forward-looking evaluation of one of the most strategically important segments of the in vitro diagnostics (IVD) industry.…
Price range: $8,750.00 through $12,500.00
Our Customers
